Dr. Jarett Feldman, M.D.
What this data tells you about Dr. Feldman
Dr. Jarett Feldman is a hematology & oncology specialist in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Feldman performed 45,057 Medicare services across 2,591 unique beneficiaries.
Between the years covered by Open Payments, Dr. Feldman received a total of $86 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Feldman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 35,800 | $0 | $1 |
| Dexamethasone injection (steroid) | 1,646 | $0 | $5 |
| Blood draw (venipuncture) | 1,057 | $8 | $9 |
| Complete blood count (CBC) with differential | 1,032 | $8 | $29 |
| Office visit, established patient (30-39 min) | 960 | $110 | $332 |
| Comprehensive metabolic blood panel | 763 | $10 | $58 |
| Anti-nausea injection (ondansetron/Zofran) | 624 | $0 | $5 |
| Office visit, established patient (20-29 min) | 381 | $75 | $227 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 314 | $27 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 236 | $113 | $927 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 225 | $60 | $313 |
| Ferritin level test (iron stores) | 195 | $13 | $85 |
| Iron level test | 192 | $6 | $43 |
| Transferrin (iron binding protein) level | 192 | $12 | $76 |
| Drug injection, under skin or into muscle | 168 | $13 | $89 |
| Lactate dehydrogenase (enzyme) level | 133 | $6 | $69 |
| Thyroid stimulating hormone (TSH) test | 102 | $16 | $75 |
| Carcinoembryonic antigen (cea) protein level | 97 | $19 | $121 |
| New patient office visit (45-59 min) | 82 | $148 | $510 |
| Unclassified drugs | 77 | $1 | $2 |
| Injection of additional new drug or substance into vein | 61 | $15 | $72 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 60 | $4 | $17 |
| Office visit, established patient, complex (40-54 min) | 59 | $157 | $446 |
| Vitamin B-12 level test | 54 | $15 | $91 |
| Office visit, established patient (10-19 min) | 54 | $52 | $137 |
| Folic acid level test | 53 | $14 | $93 |
| Injection, diphenhydramine hcl, up to 50 mg | 52 | $1 | $10 |
| Administration of additional new drug or substance into vein, 1 hour or less | 49 | $62 | $344 |
| Vitamin D level test | 45 | $28 | $200 |
| PSA test (prostate cancer screening) | 45 | $18 | $112 |
| Thyroxine (thyroid chemical), total | 39 | $7 | $31 |
| Lipid panel (cholesterol and triglycerides) | 31 | $13 | $82 |
| Urinalysis with microscopic exam | 27 | $3 | $15 |
| Hemoglobin A1c test (diabetes monitoring) | 26 | $10 | $58 |
| New patient office visit, complex (60-74 min) | 26 | $177 | $642 |
| C-reactive protein test (inflammation marker) | 23 | $5 | $25 |
| Measurement of hepatitis a antibody | 21 | $12 | $55 |
| Hepatitis c antibody measurement | 21 | $14 | $60 |
| Initial hospital admission, high complexity | 21 | $158 | $620 |
| Creatinine test (kidney function) | 14 | $5 | $25 |
Industry Payment Transparency
Open Payments through 2021 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2021)
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2021 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Feldman is a mixed practice specialist, with above-average Medicare volume (top 21% in TX), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Feldman experienced with iron sucrose injection (venofer)?
Does Dr. Feldman receive payments from pharmaceutical companies?
How do Dr. Feldman's costs compare to other hematology & oncology specialists in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology